JP2017513845A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017513845A5 JP2017513845A5 JP2016562206A JP2016562206A JP2017513845A5 JP 2017513845 A5 JP2017513845 A5 JP 2017513845A5 JP 2016562206 A JP2016562206 A JP 2016562206A JP 2016562206 A JP2016562206 A JP 2016562206A JP 2017513845 A5 JP2017513845 A5 JP 2017513845A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- brain
- disorder
- risk
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461982880P | 2014-04-23 | 2014-04-23 | |
| US61/982,880 | 2014-04-23 | ||
| PCT/IL2015/050426 WO2015162615A1 (en) | 2014-04-23 | 2015-04-22 | Quinazoline scaffold based compounds, pharmaceutical compositions and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017513845A JP2017513845A (ja) | 2017-06-01 |
| JP2017513845A5 true JP2017513845A5 (enExample) | 2018-06-07 |
| JP6498695B2 JP6498695B2 (ja) | 2019-04-10 |
Family
ID=53276956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016562206A Expired - Fee Related JP6498695B2 (ja) | 2014-04-23 | 2015-04-22 | キナゾリン骨格系の化合物、医薬組成物およびその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10035780B2 (enExample) |
| EP (1) | EP3134389B1 (enExample) |
| JP (1) | JP6498695B2 (enExample) |
| CN (1) | CN106458933B (enExample) |
| IL (1) | IL248578A0 (enExample) |
| WO (1) | WO2015162615A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10035780B2 (en) | 2014-04-23 | 2018-07-31 | Technion Research & Development Foundation Ltd. | Quinazoline scaffold based compounds, pharmaceutical compositions and methods of use thereof |
| CN120500344A (zh) * | 2022-10-31 | 2025-08-15 | 耶达研究及发展有限公司 | 调理方案同抗病毒中央型记忆cd8+反抑细胞用于单倍体相同的干细胞移植中的用途 |
| WO2024095268A1 (en) * | 2022-11-02 | 2024-05-10 | Technion Research & Development Foundation Limited | Translocator protein ligands and inflammatory diseases |
| CN116410180B (zh) * | 2023-03-01 | 2024-09-10 | 青岛大学 | 4-氧代喹啉-3-甲酰胺衍生物及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2525595A1 (fr) | 1982-04-27 | 1983-10-28 | Pharmuka Lab | Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments |
| FR2538388B1 (fr) | 1982-12-24 | 1985-06-21 | Pharmuka Lab | Nouveaux derives de naphtalene- ou azanaphtalenecarboxamide, leurs procedes de preparation et leur utilisation comme medicaments |
| US5716956A (en) | 1995-06-07 | 1998-02-10 | Bearsden Bearsden Bio, Inc. | Dihydrophthalazine antagonists of excitatory amino acid receptors |
| DE19617863A1 (de) | 1996-04-23 | 1997-10-30 | Schering Ag | Phthalazinderivate, deren Herstellung und Verwendung als Arzneimittel |
| JP2002505288A (ja) | 1998-03-02 | 2002-02-19 | コセンシス，インコーポレイテッド | 置換キナゾリンおよびアナログならびにそれらの使用 |
| JP2004256473A (ja) | 2003-02-27 | 2004-09-16 | Ono Pharmaceut Co Ltd | エラスターゼ阻害活性を有する１，３，４−オキサジアゾール誘導体 |
| CL2004000409A1 (es) | 2003-03-03 | 2005-01-07 | Vertex Pharma | Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu |
| US8541428B2 (en) | 2006-08-22 | 2013-09-24 | Technion Research And Development Foundation Ltd. | Heterocyclic derivatives, pharmaceutical compositions and methods of use thereof |
| US10035780B2 (en) | 2014-04-23 | 2018-07-31 | Technion Research & Development Foundation Ltd. | Quinazoline scaffold based compounds, pharmaceutical compositions and methods of use thereof |
-
2015
- 2015-04-22 US US15/304,958 patent/US10035780B2/en active Active
- 2015-04-22 CN CN201580025361.4A patent/CN106458933B/zh active Active
- 2015-04-22 EP EP15726741.0A patent/EP3134389B1/en active Active
- 2015-04-22 WO PCT/IL2015/050426 patent/WO2015162615A1/en not_active Ceased
- 2015-04-22 JP JP2016562206A patent/JP6498695B2/ja not_active Expired - Fee Related
-
2016
- 2016-10-25 IL IL248578A patent/IL248578A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7532561B2 (ja) | 医学的障害の治療のためのアリール、ヘテロアリール及び複素環式化合物 | |
| JP2017513845A5 (enExample) | ||
| Jenner | Istradefylline, a novel adenosine A2A receptor antagonist, for the treatment of Parkinson’s disease | |
| JP2017527532A5 (enExample) | ||
| FI3487505T3 (fi) | Diaminofenotiatsiinien antaminen ja annostus | |
| JP2013526544A5 (enExample) | ||
| JP2014065696A5 (enExample) | ||
| JP2018507886A5 (enExample) | ||
| JP2015163632A (ja) | 新規な三環式化合物 | |
| JP2017519807A5 (enExample) | ||
| JP2010520889A5 (enExample) | ||
| JP2004525142A5 (enExample) | ||
| JP2014517050A5 (enExample) | ||
| JP2011504474A5 (enExample) | ||
| JP2020186274A5 (enExample) | ||
| CA2815537A1 (en) | Inhibitors of hepatitis c virus | |
| RU2003124059A (ru) | Лечение неврологической дисфункции с применением сульфаматов фруктопиранозы и эритропоэтина | |
| JP2019534327A5 (enExample) | ||
| JP2017523202A5 (enExample) | ||
| JP2013224953A5 (enExample) | ||
| JP2017535569A5 (enExample) | ||
| JP2017528515A5 (enExample) | ||
| JP2017523201A5 (enExample) | ||
| JP2014508758A5 (enExample) | ||
| JP2021504326A5 (enExample) |